The National Cancer Institute is offering a research grant to investigate the biological pathways linking physical activity and weight control to cancer prognosis and survival among cancer survivors. The grant seeks to conduct clinical trials testing the effects of physical activity and weight control on cancer biomarkers, including those related to comorbid diseases and aging. Researchers are encouraged to use transdisciplinary approaches to explore these pathways and foster collaborations between behavioral intervention experts, cancer biologists, and other relevant scientific disciplines. Closing date for applications is September 7, 2021.
Opportunity ID: 308053
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-892 |
| Funding Opportunity Title: | Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 07, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2021 |
| Current Closing Date for Applications: | Sep 07, 2021 |
| Archive Date: | Oct 13, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments City or township governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Small businesses Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival. Research applications should test the effects of physical activity, alone or in combination with weight control (either weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among cancer survivors identified by previous animal or observational research on established biomarkers other than insulin/glucose metabolism, especially those obtained from tumor tissue sourced from repeat biopsies where available. Because many cancer survivor populations will not experience recurrence but will die of comorbid diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases (e.g., cardiovascular disease) and of the aging process are also sought. Applications should use experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial designs), and will include transdisciplinary approaches that bring together behavioral intervention expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways being studied. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-892.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00244272 | Sep 16, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259958 | Sep 16, 2018 | Sep 07, 2021 | View |
Package 1
Mandatory forms
308053 RR_SF424_2_0-2.0.pdf
308053 PHS398_CoverPageSupplement_4_0-4.0.pdf
308053 RR_OtherProjectInfo_1_4-1.4.pdf
308053 PerformanceSite_2_0-2.0.pdf
308053 RR_KeyPersonExpanded_2_0-2.0.pdf
308053 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
308053 RR_Budget_1_4-1.4.pdf
308053 RR_SubawardBudget30_1_4-1.4.pdf
308053 PHS398_ModularBudget_1_2-1.2.pdf
308053 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
308053 RR_SF424_2_0-2.0.pdf
308053 PHS398_CoverPageSupplement_5_0-5.0.pdf
308053 RR_OtherProjectInfo_1_4-1.4.pdf
308053 PerformanceSite_2_0-2.0.pdf
308053 RR_KeyPersonExpanded_2_0-2.0.pdf
308053 PHS398_ResearchPlan_4_0-4.0.pdf
308053 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
308053 RR_Budget_1_4-1.4.pdf
308053 RR_SubawardBudget30_1_4-1.4.pdf
308053 PHS398_ModularBudget_1_2-1.2.pdf
308053 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
